European Diabetes Leadership Forum Participation Report
date : 4/26/2012
This forum was held as a meeting for high-level discussions on how diabetes control could act as a model case for progression in the area of chronic disease control. It aimed to reflect on the magnitude of the influence of diabetes prevalence in Europe, and hold discussions from the perspective of prevention, early detection, and improvement of treatment. The forum was organized by the Organization for Economic Co-operation and Development (OECD) together with the Danish Diabetes Association (DDA), with backing from the Danish government and Danish Health Ministry and support from the company Novo Nordisk. Around 760 people attended, with participants representing government, industry, academia, and patients present from all over the world, including EU Member States, European Free Trade Association Member States, EU non-member states, and OECD Member States.
Speeches were also made by the Danish Prime Minister and Minister of Health and Welfare, as well as Kofi Annan, former U.N. Secretary-General. The importance of comprehensive approaches which transcend health policy frameworks was emphasized, together with the importance of policies which bridge patient and multi-stakeholder involvement in prevention with treatment. Furthermore, it was also re-recognized that diabetes control does not just end with the formulation of a road map as actual implementation is also important, and to this end patient empowerment and cooperative activities between different sectors were highlighted as being additionally important.
Exhibition date:2012-04-26
Top Research & Recommendations Posts
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Recommendations] “Balancing Sustainability and Innovation in the Healthcare System” (December 26, 2025)
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
Featured Posts
-
2026-01-09
[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)
-
2026-01-22
[Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
-
2026-01-26
[HGPI Policy Column] (No.68) – From the Intractable and Rare Diseases Project “Part 2 – Making Intractable and Rare Diseases a Priority Issue for the International Community: The WHA Resolution’s Vision for a Global Action Plan and Japan’s Role”
-
2026-01-26
[Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)



